Dossier health check
Identify gaps and inconsistencies before inspection or major variation work.
AI-powered regulatory intelligence that identifies gaps, classifies variations, and drafts Module 3 updates — in hours, not weeks.
Built for Regulatory Affairs. Designed for compliance. Trusted by experts.
Public information site — sign-in and analysis run in your organisation’s application instance.
Most Marketing Authorisation Holders are operating with legacy dossiers no longer aligned with manufacturing reality, undocumented or partially implemented changes, increasing regulatory scrutiny, and significant time spent on manual gap analysis.
Every variation becomes harder because:
This is not a documentation problem. It’s a regulatory risk problem.
A secure AI platform that compares your registered Module 3 dossier against your current manufacturing source data and delivers a complete, submission-ready variation package — with regulatory-grade classification and citations, not generic text.
From ingest to submission-ready outputs — structured, traceable, and aligned with the EU variations framework.
Upload: your current registered dossier (Module 3) and the latest source documents from manufacturing.
AI performs a structured comparison: every deviation from the approved state, with evidence-backed differences.
Each change is classified (Type IA / IAIN / IB / II), assigned the correct EU variation code, and supported with regulatory citations.
Automatically generates updated Module 3 sections, clean and tracked-change versions, in regulatory-grade language.
Outputs: change list for eAF, supporting document map, and an audit-ready report — fully aligned with EU variations expectations.
What you receive in a single AI-assisted run:
What normally takes two to four weeks of senior RA time can be compressed into a single assisted run — with human sign-off on every decision that matters.
Eliminate regulatory blind spots
This is not automation replacing Regulatory Affairs. AI does the heavy lifting; experts make the final decision.
“The first AI platform designed to think like a Regulatory CMC reviewer.”
Trust comes before technology. Pharma buyers care about compliance, defensibility, and inspection readiness — not model names.
Where teams get the most leverage from a structured dossier baseline.
Identify gaps and inconsistencies before inspection or major variation work.
Establish a clean, trusted baseline before the next round of submissions.
Rapidly assess impact and required variations when manufacturing moves or scales.
Reconcile legacy dossiers and sources at scale with consistent methodology.
RegAIDossierIQ is the foundation for multi-region regulatory intelligence, change-control-driven automation, and full lifecycle regulatory management — always with regulatory augmentation, not “black box” replacement of your experts.
Run a secure AI-powered dossier analysis and receive a gap report, variation roadmap, and draft CTD updates — scoped to your deployment and governance model.
Request a demo